SARS-CoV2
Showing NaN - NaN of 4
Sars-CoV2, Covid-19 Trial in Brazil, Canada (Peginterferon Lambda-1A, )
Recruiting
- Sars-CoV2
- Covid-19
- Peginterferon Lambda-1A
- placebo
-
Botucatu, Brazil
- +6 more
Jan 17, 2022
Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Trial in Sao Paulo (Janus Kinase Inhibitor (ruxolitinib), Placebo)
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2
- SARS-CoV2
- Janus Kinase Inhibitor (ruxolitinib)
- Placebo
-
Sao Paulo, BrazilHospital das ClĂnicas
Apr 5, 2021
Sars-CoV2 Trial in Brazil (Hydroxychloroquine and Azithromycin)
Withdrawn
- Sars-CoV2
- Hydroxychloroquine and Azithromycin
-
Salvador, BA, Brazil
- +6 more
Oct 2, 2020